OPIANT PHARMACEUTICALS, INC. Quarterly Return On Equity in % from Q1 2012 to Q3 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Opiant Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q3 2022.
  • Opiant Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2022 was -97.2 %, a 2386% decline year-over-year.
  • Opiant Pharmaceuticals, Inc. annual Return On Equity for 2021 was 7.56 %.
  • Opiant Pharmaceuticals, Inc. annual Return On Equity for 2020 was -5.35 %, a 112% decline from 2019.
  • Opiant Pharmaceuticals, Inc. annual Return On Equity for 2019 was 45.1 %.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2022 -97.2 -101 -2386% Jul 1, 2022 Sep 30, 2022
Q2 2022 -50.1 -46.9 -1479% Apr 1, 2022 Jun 30, 2022
Q1 2022 -15.4 -6.73 -77.6% Jan 1, 2022 Mar 31, 2022
Q4 2021 7.56 +12.9 Oct 1, 2021 Dec 31, 2021
Q3 2021 4.25 +4.56 Jul 1, 2021 Sep 30, 2021
Q2 2021 -3.17 -32.6 -111% Apr 1, 2021 Jun 30, 2021
Q1 2021 -8.67 -47.5 -122% Jan 1, 2021 Mar 31, 2021
Q4 2020 -5.35 -50.4 -112% Oct 1, 2020 Dec 31, 2020
Q3 2020 -0.31 -4.94 -107% Jul 1, 2020 Sep 30, 2020
Q2 2020 29.4 +83.2 Apr 1, 2020 Jun 30, 2020
Q1 2020 38.9 +120 Jan 1, 2020 Mar 31, 2020
Q4 2019 45.1 +196 Oct 1, 2019 Dec 31, 2019
Q3 2019 4.63 +67.9 Jul 1, 2019 Sep 30, 2019
Q2 2019 -53.8 +104 +65.9% Apr 1, 2019 Jun 30, 2019
Q1 2019 -80.9 +76.1 +48.5% Jan 1, 2019 Mar 31, 2019
Q4 2018 -150 -102 -213% Oct 1, 2018 Dec 31, 2018
Q3 2018 -63.2 -191 -149% Jul 1, 2018 Sep 30, 2018
Q2 2018 -158 -475 -150% Apr 1, 2018 Jun 30, 2018
Q1 2018 -157 -6.17K -103% Jan 1, 2018 Mar 31, 2018
Q4 2017 -48.1 +446 +90.3% Oct 1, 2017 Dec 31, 2017
Q3 2017 128 +187 Jul 1, 2017 Sep 30, 2017
Q2 2017 317 +178 +129% Apr 1, 2017 Jun 30, 2017
Q1 2017 6.01K +5.88K +4612% Jan 1, 2017 Mar 31, 2017
Q4 2016 -494 -639 -441% Nov 1, 2016 Jan 31, 2017
Q3 2016 -58.4 -287 -126% Aug 1, 2016 Oct 31, 2016
Q2 2016 139 +25.5 +22.5% May 1, 2016 Jul 31, 2016
Q1 2016 128 -67.9 -34.8% Feb 1, 2016 Apr 30, 2016
Q4 2015 145 -76 -34.4% Nov 1, 2015 Jan 31, 2016
Q3 2015 228 -167 -42.3% Aug 1, 2015 Oct 31, 2015
Q2 2015 113 -404 -78.1% May 1, 2015 Jul 31, 2015
Q1 2015 195 -311 -61.4% Feb 1, 2015 Apr 30, 2015
Q4 2014 221 -475 -68.3% Nov 1, 2014 Jan 31, 2015
Q3 2014 395 -520 -56.8% Aug 1, 2014 Oct 31, 2014
Q2 2014 517 -568 -52.3% May 1, 2014 Jul 31, 2014
Q1 2014 506 -763 -60.1% Feb 1, 2014 Apr 30, 2014
Q4 2013 696 -688 -49.7% Nov 1, 2013 Jan 31, 2014
Q3 2013 915 -615 -40.2% Aug 1, 2013 Oct 31, 2013
Q2 2013 1.09K -1.96K -64.4% May 1, 2013 Jul 31, 2013
Q1 2013 1.27K -2.74K -68.4% Feb 1, 2013 Apr 30, 2013
Q4 2012 1.38K Nov 1, 2012 Jan 31, 2013
Q3 2012 1.53K Aug 1, 2012 Oct 31, 2012
Q2 2012 3.05K May 1, 2012 Jul 31, 2012
Q1 2012 4.01K Feb 1, 2012 Apr 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.